Wenn Sie das Fenster schließen, wird Ihre Konfiguration nicht gespeichert, es sei denn, Sie haben Ihren Artikel in die Bestellung aufgenommen oder zu Ihren Favoriten hinzugefügt.
Klicken Sie auf OK, um das MILLIPLEX® MAP-Tool zu schließen oder auf Abbrechen, um zu Ihrer Auswahl zurückzukehren.
Wählen Sie konfigurierbare Panels & Premixed-Kits - ODER - Kits für die zelluläre Signaltransduktion & MAPmates™
Konfigurieren Sie Ihre MILLIPLEX® MAP-Kits und lassen sich den Preis anzeigen.
Konfigurierbare Panels & Premixed-Kits
Unser breites Angebot enthält Multiplex-Panels, für die Sie die Analyten auswählen können, die am besten für Ihre Anwendung geeignet sind. Unter einem separaten Register können Sie das Premixed-Cytokin-Format oder ein Singleplex-Kit wählen.
Kits für die zelluläre Signaltransduktion & MAPmates™
Wählen Sie gebrauchsfertige Kits zur Erforschung gesamter Signalwege oder Prozesse. Oder konfigurieren Sie Ihre eigenen Kits mit Singleplex MAPmates™.
Die folgenden MAPmates™ sollten nicht zusammen analysiert werden: -MAPmates™, die einen unterschiedlichen Assaypuffer erfordern. -Phosphospezifische und MAPmate™ Gesamtkombinationen wie Gesamt-GSK3β und Gesamt-GSK3β (Ser 9). -PanTyr und locusspezifische MAPmates™, z.B. Phospho-EGF-Rezeptor und Phospho-STAT1 (Tyr701). -Mehr als 1 Phospho-MAPmate™ für ein einziges Target (Akt, STAT3). -GAPDH und β-Tubulin können nicht mit Kits oder MAPmates™, die panTyr enthalten, analysiert werden.
.
Bestellnummer
Bestellinformationen
St./Pkg.
Liste
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Wählen Sie bitte Spezies, Panelart, Kit oder Probenart
Um Ihr MILLIPLEX® MAP-Kit zu konfigurieren, wählen Sie zunächst eine Spezies, eine Panelart und/oder ein Kit.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Spezies
Panelart
Gewähltes Kit
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
96-Well Plate
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
Weitere Reagenzien hinzufügen (MAPmates erfordern die Verwendung eines Puffer- und Detektionskits)
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Platzsparende Option Kunden, die mehrere Kits kaufen, können ihre Multiplex-Assaykomponenten in Kunststoffbeuteln anstelle von Packungen erhalten, um eine kompaktere Lagerung zu ermöglichen.
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Das Produkt wurde in Ihre Bestellung aufgenommen
Sie können nun ein weiteres Kit konfigurieren, ein Premixed-Kit wählen, zur Kasse gehen oder das Bestell-Tool schließen.
SCC440
Sigma-AldrichSK-MEL-147 Human Melanoma Cell Line
The SK-MEL-147 cell line expresses PMEL and MelanA proteins, two common melanoma markers. PMEL has been implicated in poor immune cell infiltration, and may be a relevant target for drug therapy due to its limited expression in normal cell phenotypes.
More>> The SK-MEL-147 cell line expresses PMEL and MelanA proteins, two common melanoma markers. PMEL has been implicated in poor immune cell infiltration, and may be a relevant target for drug therapy due to its limited expression in normal cell phenotypes. Less<<
Empfohlene Produkte
Übersicht
Replacement Information
Description
Catalogue Number
SCC440
Description
SK-MEL-147 Human Melanoma Cell Line
Overview
SK-MEL-147 is a human metastatic melanoma cell line. It retains a Q61R NRAS point mutation which is associated with a more aggressive phenotype, higher metastasis risk, and poorer prognosis.
Alternate Names
human melanoma cell line
human melanoma cells
SK-MEL-147
metastatic melanoma cell line
Q61R NRAS melanoma cell line
Background Information
Melanoma is considered the most dangerous form of skin cancer. It develops in melanocytes, the pigment producing cells of the skin. Melanoma accounts for a very small number of all skin cancers. Even though it accounts for only about 1% of total diagnosed skin cancer cases, melanoma is responsible for the largest number of skin cancer deaths.2 Melanoma incidence rates have increased over time, although mortality rates from melanoma have improved over the last decade due to advances in treatment.
While there is enhanced understanding of BRAF-mutant melanoma and treatment strategies, therapeutic approaches to NRAS-mutant melanoma have been less successful. Development of immune therapies for NRAS-specific mutants remains highly relevant.
SK-MEL-147 retains a Q61R NRAS point mutation which is associated with a more aggressive melanoma phenotype, higher metastasis risk, and therefore a poorer prognosis.1 While there has been an improvement in understanding BRAF-mutant melanoma and its therapeutic strategies, solutions to NRAS-mutant melanoma has remained limited.
Source: SK-MEL-147 was derived from unspecified metastatic site in a patient with malignant melanoma. This cell line was developed by the LJ Old lab at Memorial Sloan Kettering Cancer Center.
References 1. Muñoz-Couselo E, Adelantado EZ, Ortiz C, García JS, Perez-Garcia J. 2017. NRAS-mutant melanoma: current challenges and future prospect. Onco Targets Ther. 10:3941-3947. 2. Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob J-J, Halpern A, Herlyn M, Marchetti MA, McArthur G, Ribas A, et al. 2015. Melanoma. Nat Rev Dis Primers. 1:15003. 3. Zhang S, Chen K, Liu H, Jing C, Zhang X, Qu C, Yu S. 2021. PMEL as a prognostic biomarker and negatively associated with immune infiltration in skin cutaneous melanoma (SKCM). J Immunother. 44(6):214-223. 4. Kaufmann WK, Nevis KR, Qu P, Ibrahim JG, Zhou T, Zhou Y, Simpson DA, Helms-Deaton J, Cordeiro-Stone M, Moore DT, et al. 2008. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression. J Invest Dermatol. 128(1):175-187. 5. Houghton AN, Brooks H, Cote RJ, Taormina MC, Oettgen HF, Old LJ. 1983. Detection of cell surface and intracellular antigens by human monoclonal antibodies. J Exp Med. 158(1): 53-65.
References
Product Information
Components
≥1x106 viable SK-MEL-147 Cells: (Catalog No. SCC440). Store in liquid nitrogen.
The SK-MEL-147 cell line expresses PMEL and MelanA proteins, two common melanoma markers. PMEL has been implicated in poor immune cell infiltration, and may be a relevant target for drug therapy due to its limited expression in normal cell phenotypes.
Key Applications
Cell Culture
Cell Function Assay
Application Notes
This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@milliporesigma.com.
Biological Information
Host
Human
Cell Line Type
Cancer Cells
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality Assurance
• Each vial contains ≥1X10⁶ viable cells. • SK-MEL-147 cells are verified to be of human origin and negative for mouse, rat, Chinese hamster, Golden Syrian hamster, and non-human primate interspecies contamination, as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services • Cells tested negative for infectious diseases against a Contamination Clear panel by Charles River Animal Diagnostic Services. • Cells tested negative for mycoplasma.
Usage Statement
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage Conditions
SK-MEL-147 cells should be stored in liquid nitrogen until use. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting cell marker expression and functionality.